Methotrexate >15 mg weekly and adalimumab as first-line therapy were positive predictors of anti-TNF-a response in patients with rheumatoid arthritis.
Rodney S. Daniel, MD
Advertisement
Articles by Rodney S. Daniel, MD
Advertisement
Latest Updated Articles
- Predictors of Response to Anti-Tumor Necrosis Factor Alpha Therapies in Rheumatoid Arthritis
Published: July 1st 2009 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Is Berberine Nature’s GLP-1?
2
Ban Synthetic 7-OH: Natural Leaf Kratom Presents No Major Health Risk
3
Glucodensity Analysis Enhances CGM Accuracy for Detecting Cystic Fibrosis–Related Diabetes
4
Experts Highlight Key Sessions and Emerging Topics from The Menopause Society 2025 Annual Meeting
5
